Diabetes Management Post-Acute and Long-Term Care Setting
Publication Date: November 2, 2015
Key Points
Key Points
- Multimorbidity, functional impairments, and psychosocial issues increases the complexity of diabetes management in the PA/LTC.
- Cardiovascular mortality, functional impairment and cognitive decline increase with hyperglycemia.
- Hypoglycemia (frequent or prolonged) can cause cognitive impairment, falls and functional impairment. Prolonged or frequent hypoglycemia can affect cognition and increase the chance of falls, seizures and stroke.
- Cardiovascular mortality, cognitive decline, falls and functional impairment are increased in older adults with DM.
General
The management of patients with diabetes in the PA-LTC setting should be individualized and guided by functional and cognitive status, patient preference, and life expectancy ( Strong , Low )
704
The medication regimen for diabetes should be verified and communicated to receiving practitioners if the patient is transferred to another site of care ( Strong , Low )
704
Recognition
Patients in the PA-LTC setting should be screened for diabetes or pre-diabetes unless they are terminally ill. ( Strong , Moderate )
704
Factors causing or exacerbating hyperglycemia should be sought. ( Strong , Low )
704
Assessment
Patients with diabetes should be evaluated for the presence of macrovascular and microvascular complications. ( Strong , High )
704
Patients with diabetes should be assessed for the presence of cognitive impairment. ( Weak , Low )
704
Patients with diabetes should be assessed for the presence of depression. ( Strong , High )
704
Patients with diabetes should be assessed for the presence of foot complications. ( Strong , Moderate )
704
Treatment/Management
In general, patients with diabetes should be offered a regular diet. ( Strong , Low )
704
In general, metformin is preferred as an initial oral medication for the treatment of diabetes in the absence of absolute or relative contraindications. ( Strong , Low )
704
If treatment with insulin is required, basal insulin is the preferred initial choice if its use can achieve glycemic targets. ( Strong , Low )
704
The use of sliding-scale insulin alone to control blood glucose levels should be avoided. ( Strong , Moderate )
704
It is reasonable to aim for A1C targets between 7.5% and 8.5% for most patients, although higher targets may be appropriate for certain individuals. ( Strong , Moderate )
704
A blood-pressure goal of less than 150/90 is recommended for most older patients with diabetes. ( Strong , High )
704
Statin therapy is recommended for all older patients with diabetes who are able to tolerate it and who lack contraindications. ( Strong , High )
704
Monitoring
Blood glucose patterns should be reviewed regularly to allow logical adjustment of the pharmacological regimen. ( Strong , Low )
704
Patients being treated for diabetes should be monitored for the occurrence of hypoglycemia and the treatment regimen adjusted as necessary. ( Strong , Moderate )
704
The facility should monitor its management of patients with diabetes by measuring and tracking selected relevant process and outcome indicators. ( Strong , Moderate )
704
Recognition
...ge and Skills Needed by Interprofessional Team Me...
...s Diabetes Present?...
...roblems and Complications Associat...
...r a Diagnosis of Diabetesa...
...atory Values Indicating Prediabetesa...
...or Possible Diabetes in Patients Wit...
Assessment
...3: Identify Factors Contributing to the...
...aluate the Nature and Severity of Diabetic Com...
Suggested Approach to Screening for Diab...
...EP 5: Identify the Impact of Diabetes on...
Treatment
...an Individualized Care Plan and Define the Goal...
...plement the Care Plan ...
...n to Use Insulin
Persisten...
...1. Stepwise Approach to Antihyperglycemic Ther...
...ew of Available Oral Antidiabetic AgentsHav...
...verview of Non-Insulin Injectable Antidiabe...
...Insulin and Their PharmacokineticsHaving troub...
...ation Recommendations for Adults With D...
...ngly supports pneumococcal vaccinati...
...gested Insulin Regimens For Different...
...tions for Adjusting Insulin Therapy...
...n Therapy (basal insulin with rapid acting insu...
...ulin Therapy (regular and NPH, give...
...ossible Symptoms and Signs of Hypog...
Monitoring
STEP 8: Re-evaluate the Patient Peri...
...the patient with newly diagnosed di...
...ular attention to the following:
Overall...
...onitor the Patient’s Blood Glucose Levels...
...ggested Monitoring of Blood Glucose by Type of...
...P 10: Individualize Diabetes and Management o...
...th risk factors for developing diabetes should...
...se with signs and symptoms of hyperglycemia...
...Monitor the Facility's Management of Diabetes...
...ome indicators
Prevalence of hypoglycemic e...
...ndicators
Appropriate recogni...
